2004
DOI: 10.1096/fj.04-1813fje
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione depletion up‐regulates Bcl‐2 in BSO‐resistant cells

Abstract: Glutathione depletion by inhibition of its synthesis with buthionine sulfoximine (BSO) is a focus of the current research in antitumor therapy, BSO being used as chemosensitizer. We had previously shown that two human tumor cell lines (U937 and HepG2) survive to treatment with BSO: BSO can elicit an apoptotic response, but the apoptotic process is aborted after cytochrome c release and before caspase activation, suggesting the development of an adaptive response (FASEB J., 1999, 13, 2031-2036). Here, we invest… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
54
0
3

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(58 citation statements)
references
References 37 publications
(44 reference statements)
1
54
0
3
Order By: Relevance
“…In cholangiocytes, GSH depletion down-regulated Bcl-2 by reducing its half-life (Celli et al, 1998), whereas in human colon cancer cells, NAC-induced elevation in GSH level was accompanied with increased Bcl-2 expression (Ho et al, 1997). D'Alessio et al (2004) isolated two tumor cell lines (from U937 and HEpG2 cells) resistant to BSO treatment that up-regulate Bcl-2 in response to BSO. We did not observe difference in Bcl-2 expression after GSH depletion or after increase in GSH levels by NAC treatment in human laryngeal carcinoma cells (data not shown), suggesting no interaction between Bcl-2 and GSH in HEp2 cells and presence of at least two signaling pathways triggered by ␣ v ␤ 3 integrin.…”
Section: Downloaded Frommentioning
confidence: 99%
See 1 more Smart Citation
“…In cholangiocytes, GSH depletion down-regulated Bcl-2 by reducing its half-life (Celli et al, 1998), whereas in human colon cancer cells, NAC-induced elevation in GSH level was accompanied with increased Bcl-2 expression (Ho et al, 1997). D'Alessio et al (2004) isolated two tumor cell lines (from U937 and HEpG2 cells) resistant to BSO treatment that up-regulate Bcl-2 in response to BSO. We did not observe difference in Bcl-2 expression after GSH depletion or after increase in GSH levels by NAC treatment in human laryngeal carcinoma cells (data not shown), suggesting no interaction between Bcl-2 and GSH in HEp2 cells and presence of at least two signaling pathways triggered by ␣ v ␤ 3 integrin.…”
Section: Downloaded Frommentioning
confidence: 99%
“…Bcl-2 overexpression causes redistribution of GSH to the nucleus, thereby altering nuclear redox potential (Voehringer et al, 1998) and by raising cellular antioxidant defense status decreases formation of some oxidative reactive nitrogen species (Lee et al, 2001). However, U937 monocytic tumor cells treated with buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, up-regulated Bcl-2 expression that supported their survival (D'Alessio et al, 2004). In contrast, BSO caused GSH depletion down-regulated Bcl-2 by reducing protein half-life and induced cholangiocyte apoptosis (Celli et al, 1998).…”
mentioning
confidence: 99%
“…CySS is the predominant form in the plasma, and extensive research has characterized Cys and CySS transport systems (2) and utilization of Cys and CySS for cell growth (3,27) and protection against oxidative stress (4). Inhibition of Cys incorporation into GSH by L-buthionine-[S,R]-sulfoximine (BSO) sensitizes many cell types to anticancer therapy (6), and supply of N-acetyl-L-cysteine and other Cys precursors is a common approach to enhance antioxidant defenses (21).…”
mentioning
confidence: 99%
“…The antioxidant glutathione is part of one of the most important redox system in mammalian cells. 44 Buthionine sulfoximine (BSO) is known to deplete glutathione, 45,46 which in turn increases ROS levels. Consistently, when mice were treated with BSO, elevated ROS production could be observed in granulocytes (Figures 6a).…”
Section: Glutathione Depletion By Buthionine Sulfoximine Influences Cd8mentioning
confidence: 99%